Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Helianthus Annuus
Brand Name
Helianthus Annuus
Generic Name
Helianthus Annuus
Active Ingredient
Helianthus Annuus Flowering TopCategory
Non-Standardized Plant Allergenic Extract [EPC]
Variants
8
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 6 [hp_C]/1 | PELLET | ORAL | 37662-0800 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-0806 |
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-0807 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Helianthus Annuus, you must consult a qualified healthcare professional.
| 200 [hp_C]/1 | PELLET | ORAL | 37662-0804 |
| 12 [hp_C]/1 | PELLET | ORAL | 37662-0801 |
| 30 [hp_C]/1 | PELLET | ORAL | 37662-0802 |
| 100 [hp_C]/1 | PELLET | ORAL | 37662-0803 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-0805 |
Detailed information about Helianthus Annuus
Helianthus Annuus Flowering Top is a non-standardized plant allergenic extract used primarily in the diagnosis and treatment of IgE-mediated allergic diseases. It belongs to the Asteraceae family and is utilized in skin prick testing and allergen immunotherapy.
Dosage for Helianthus Annuus Flowering Top is highly individualized and must be determined by an allergy specialist based on the patient's sensitivity levels and the specific clinical objective.
For skin prick testing, a single drop of the 1:10 or 1:20 w/v concentrate is applied to the skin (usually the forearm or back). A sterile lancet is then used to prick the skin through the drop. A positive control (histamine) and a negative control (saline/glycerin) are always used simultaneously for comparison.
If the prick test is negative but clinical suspicion remains high, an intradermal test may be performed. The dose typically involves the injection of 0.02 mL to 0.05 mL of a 1:1000 or 1:500 v/v dilution into the dermis. This is significantly more sensitive and carries a higher risk of systemic reaction.
If used for immunotherapy, the 'Build-up Phase' usually begins with a very low dose (e.g., 0.1 mL of a 1:100,000 dilution) administered once or twice weekly. The dose is gradually increased over 3 to 6 months until the 'Maintenance Dose' is reached (typically 0.5 mL of a 1:100 or 1:10 concentration). Maintenance injections are then given every 2 to 4 weeks.
Helianthus Annuus Flowering Top extracts are generally considered safe for use in children, provided they are administered by a pediatric allergist. There is no specific age-based weight adjustment; however, the number of skin tests performed in a single session may be limited in infants to minimize discomfort and the risk of systemic absorption. Immunotherapy is rarely initiated in children under the age of 5 due to the difficulty of monitoring for early signs of systemic reactions.
No specific dosage adjustments are required for patients with renal impairment, as the systemic load of protein is minimal. However, patients with end-stage renal disease may have altered skin reactivity, potentially leading to false-negative results in diagnostic testing.
No dosage adjustments are necessary for hepatic impairment. The metabolism of allergenic proteins is not dependent on liver function.
In patients over 65, skin reactivity may be diminished (atrophy of the skin and reduced mast cell density). Physicians may need to interpret results with caution and consider that elderly patients are at higher risk if a systemic reaction (anaphylaxis) occurs due to underlying cardiovascular disease.
This agent is never for self-administration. It must be administered by a qualified healthcare professional in a medical facility.
In the context of immunotherapy, a missed dose can disrupt the desensitization process. If a dose is missed by more than a week, the physician may need to reduce the next dose to ensure safety. If several weeks are missed, the build-up process may need to be restarted from a lower concentration.
An 'overdose' in the context of allergenic extracts typically refers to the administration of a concentration higher than what the patient can tolerate, leading to a systemic allergic reaction. Signs include generalized hives (urticaria), swelling of the throat (angioedema), wheezing, and a drop in blood pressure. Immediate treatment with epinephrine (EpiPen) and emergency medical care is required.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or skip appointments without medical guidance.
The most frequent side effects associated with Helianthus Annuus Flowering Top are localized to the site of administration. These are often expected as part of the diagnostic process:
Helianthus Annuus Flowering Top is a potent biological agent. Its use is strictly limited to diagnostic and therapeutic procedures under the supervision of an allergist. It is not a 'natural supplement' in this context, but a regulated medical extract. Patients must provide a full medical history, specifically focusing on cardiovascular health and respiratory status, before undergoing testing.
No FDA black box warnings specifically for Helianthus Annuus Flowering Top exist as a unique entity, but it falls under the General Black Box Warning for Allergenic Extracts. This warning emphasizes that these products can cause anaphylaxis, may be fatal, and must be administered in a setting capable of providing advanced cardiac life support (ACLS).
Helianthus Annuus Flowering Top is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. The primary risk is not teratogenicity (birth defects) but the indirect effect of maternal anaphylaxis. If the mother experiences a severe drop in blood pressure or respiratory failure, the fetus may suffer from hypoxia (lack of oxygen). Therefore, skin testing and the initiation of immunotherapy are typically postponed until postpartum. If a woman is already on a stable maintenance dose of immunotherapy and becomes pregnant, the physician may choose to continue the treatment at a reduced or constant dose, as the risk of a reaction is lower during the maintenance phase.
It is not known whether the allergenic proteins or their metabolites are excreted in human milk. However, because these are large proteins that are likely digested in the infant's gut, the risk to a nursing child is considered minimal. The decision to continue immunotherapy while breastfeeding should be based on the mother's clinical need for allergy control.
Helianthus Annuus Flowering Top is used in children for diagnostic purposes. It is generally safe, but clinicians must be cautious about the 'psychological' impact of needle testing, which can lead to vasovagal episodes. For immunotherapy, children under age 5 are often excluded because they may not be able to articulate the early 'itchy throat' or 'tight chest' symptoms that signal the onset of a systemic reaction.
Helianthus Annuus Flowering Top acts as a specific antigen that probes the immune system's sensitivity. At the molecular level, the extract contains various proteins (such as Hel a 1, a 34-kDa protein). In a sensitized individual, these proteins bind to the Fab portion of IgE antibodies that are already 'loaded' onto the high-affinity IgE receptor (FcεRI) on mast cells. This binding causes the receptors to cluster (cross-link), activating an intracellular signaling cascade involving tyrosine kinases (like Syk). This results in the rapid release of pre-formed mediators (histamine) and the synthesis of new mediators (leukotrienes), causing the clinical allergic response.
The dose-response relationship in skin testing is typically logarithmic. A ten-fold increase in allergen concentration usually leads to a predictable increase in the diameter of the wheal. The time to onset for a skin prick test is 5-10 minutes, with a peak effect at 15-20 minutes. The duration of the visible wheal is usually 1-2 hours, though the underlying immunological 'priming' can last much longer.
Common questions about Helianthus Annuus
Helianthus Annuus Flowering Top is primarily used as a diagnostic tool to identify if a person has an allergy to sunflower pollen or related plants in the Asteraceae family. It is administered by an allergist through a skin prick test, where a small amount of the extract is introduced into the skin to see if a localized reaction occurs. In some specialized cases, it may also be used in allergen immunotherapy, commonly known as allergy shots, to help desensitize the immune system over time. This process involves giving gradually increasing doses of the extract to reduce the severity of allergic symptoms. It is not a treatment for acute allergic reactions and should only be used for long-term diagnosis and management.
The most common side effects are localized to the site where the extract was applied or injected, such as the arm or back. Patients typically experience a 'wheal and flare' reaction, which looks like a small, itchy mosquito bite surrounded by a patch of red skin. This is a normal part of the testing process and usually fades within an hour or two. Some patients may also experience localized swelling, itching, or redness that lasts for a day or two after an immunotherapy injection. While these local reactions are common, they are generally not dangerous. However, any reaction that spreads beyond the injection site should be reported to a doctor immediately.
It is generally advised to avoid alcohol consumption on the day of your allergy testing or immunotherapy injection. Alcohol can cause blood vessels to dilate (expand), which may speed up the absorption of the allergen into your bloodstream and potentially increase the risk or severity of a systemic allergic reaction. Furthermore, alcohol can sometimes mask the early symptoms of a reaction, making it harder for you or your doctor to identify a problem. To ensure the highest level of safety, wait at least 24 hours after your treatment before consuming alcoholic beverages. Always follow the specific guidance provided by your allergy specialist regarding lifestyle restrictions.
The use of Helianthus Annuus Flowering Top during pregnancy is approached with significant caution. While the extract itself does not cause birth defects, a severe allergic reaction (anaphylaxis) in the mother can lead to a dangerous drop in oxygen levels for the baby. For this reason, doctors usually do not start new allergy testing or begin the 'build-up' phase of allergy shots while a patient is pregnant. If a patient is already on a stable maintenance dose and is tolerating it well, the doctor may decide to continue the treatment. However, this is a complex medical decision that requires a thorough discussion between the patient, their allergist, and their obstetrician.
For diagnostic purposes, Helianthus Annuus Flowering Top works very quickly, with skin test results appearing within 15 to 20 minutes of application. This allows for an immediate diagnosis during a single office visit. However, if the extract is being used for immunotherapy (allergy shots), the process is much slower. It typically takes 3 to 6 months of weekly injections to reach a maintenance dose, and patients may not notice a significant reduction in their allergy symptoms for 6 to 12 months. For the best long-term results, immunotherapy is usually continued for 3 to 5 years to provide lasting protection against allergies.
Yes, you can stop using Helianthus Annuus Flowering Top suddenly without experiencing physical withdrawal symptoms like those associated with some other medications. However, if you are undergoing immunotherapy, stopping the injections will cause your allergy protection to gradually fade, and your original symptoms will likely return over time. If you miss multiple doses, you cannot simply resume at the same dose, as your sensitivity may have increased, raising the risk of a reaction. You must consult your allergist before stopping or restarting treatment to ensure a safe transition and to discuss alternative ways to manage your allergies.
If you miss a scheduled immunotherapy injection of Helianthus Annuus Flowering Top, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose or administer it yourself. The safety of allergy shots depends on a strict schedule; if too much time passes between doses, your doctor may need to reduce the concentration of the next injection to prevent an adverse reaction. The exact protocol for a missed dose depends on how long it has been since your last injection and whether you are in the build-up or maintenance phase of treatment.
There is no clinical evidence to suggest that Helianthus Annuus Flowering Top extracts cause weight gain. Unlike systemic corticosteroids (such as prednisone), which are known to affect metabolism and appetite, allergenic extracts work specifically on the immune system's response to proteins. The amount of protein and carbohydrate in the extract is negligible and does not affect caloric balance or hormonal regulation of weight. If you experience unexpected weight changes while undergoing allergy treatment, you should discuss them with your healthcare provider to identify other potential causes, such as changes in activity levels or other medications.
Helianthus Annuus Flowering Top can interact with several types of medications, particularly those that affect the heart or the immune system. The most significant concern is with beta-blockers, which can make it very difficult to treat a severe allergic reaction if one occurs. Antihistamines must also be avoided for several days before testing because they can block the 'wheal and flare' reaction, leading to an incorrect diagnosis. Other drugs, like ACE inhibitors or certain antidepressants, may also increase the risk of a reaction. It is vital to provide your doctor with a complete list of all prescriptions, over-the-counter drugs, and supplements you are taking.
The concept of 'generic' vs. 'brand name' is different for allergenic extracts like Helianthus Annuus Flowering Top than for standard pills. Because these are biological products derived from natural sources, they are produced by several different specialized laboratories (such as ALK, Greer, or Stallergenes Greer). While the extracts from different companies may be similar, they are not considered identical or interchangeable generics. Your allergist will typically stick with one manufacturer's extract for your entire course of treatment to ensure consistency in potency and safety. These products are generally covered by insurance when administered in a clinical setting.
Other drugs with the same active ingredient (Helianthus Annuus Flowering Top)
> Warning: Stop taking Helianthus Annuus Flowering Top and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
When used for long-term immunotherapy, there are no known cumulative toxicities to organs like the liver or kidneys. The primary long-term risk is the development of 'serum sickness-like' symptoms (joint pain, fever, rash), though this is exceedingly rare with modern purified extracts. Some patients may develop a persistent sensitivity to the extract components, requiring a modification of the treatment plan.
Allergenic extracts, including Helianthus Annuus Flowering Top, carry a standard class-wide warning regarding the risk of severe systemic reactions.
FDA-Required Warning Summary:
Report any unusual symptoms to your healthcare provider. Even a 'large' local reaction should be reported, as it may predict a systemic reaction during the next dose.
While the extract itself does not cause sedation, a systemic reaction or the administration of emergency antihistamines/epinephrine can significantly impair the ability to drive. If a patient experiences any dizziness or systemic symptoms, they should not operate machinery until cleared by a physician.
Alcohol consumption should be avoided for several hours before and after administration. Alcohol causes vasodilation (widening of blood vessels), which can increase the rate of allergen absorption and potentially worsen the severity of an allergic reaction.
If a patient experiences a systemic reaction, the use of Helianthus Annuus Flowering Top must be immediately re-evaluated. The physician may choose to discontinue the treatment, reduce the concentration, or implement a more gradual build-up schedule. There is no 'withdrawal' syndrome associated with stopping allergenic extracts, but the patient's allergy symptoms will likely return to baseline levels over time.
> Important: Discuss all your medical conditions with your healthcare provider before starting Helianthus Annuus Flowering Top.
For each major interaction, the management strategy usually involves a temporary cessation of the interfering drug (in the case of antihistamines) or a permanent switch to an alternative medication (in the case of beta-blockers for immunotherapy candidates).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients should be screened for sensitivity to other members of the Asteraceae family. A known severe allergy to ragweed (Ambrosia), mugwort (Artemisia), or dandelion (Taraxacum) increases the likelihood of a significant reaction to Helianthus Annuus Flowering Top. This is due to 'pan-allergens' such as profilins and polcalcins that are conserved across these species.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Helianthus Annuus Flowering Top.
In patients over 65, the risk-benefit ratio for immunotherapy must be carefully weighed. Older adults are more likely to have underlying coronary artery disease or hypertension, making them poor candidates for handling a systemic allergic reaction. Additionally, skin testing may be less accurate due to age-related changes in skin physiology.
There is no evidence that renal impairment affects the safety of Helianthus Annuus Flowering Top. However, uremia (high levels of waste products in the blood) can sometimes inhibit skin test reactivity, leading to potential false negatives. No specific dose adjustment is recommended, but clinical correlation is required.
Liver disease does not affect the processing of allergenic extracts. No dosage adjustments are needed for patients with cirrhosis or other hepatic conditions.
> Important: Special populations require individualized medical assessment to ensure the highest safety standards.
|---|---|
| Bioavailability | N/A (Local/Subcutaneous) |
| Protein Binding | Primarily to IgE/IgG antibodies |
| Half-life | Proteins: Minutes to Hours; Immunological Effect: Weeks |
| Tmax | 15-20 minutes (Skin Test) |
| Metabolism | Proteolytic degradation |
| Excretion | Renal (as peptide fragments) |
The extract is a complex biological mixture. The primary active components are proteins with molecular weights ranging from 10 to 70 kDa. It is soluble in aqueous buffers and is typically stabilized in a solution containing 50% glycerin and 0.45% phenol. The molecular formula cannot be defined for the whole extract as it is a multi-component biological product.
Helianthus Annuus Flowering Top is a Non-Standardized Plant Allergenic Extract. It is grouped with other botanical extracts like Ragweed, Mugwort, and Timothy Grass. These are distinct from 'Standardized' extracts (like Grass or Dust Mite), which have a potency defined in Bioequivalent Allergy Units (BAU).